Latent Labs has raised $50 million of new funding as it commercialises its GenAI technology for designing new proteins for ...

The company has assembled a team that hails from DeepMind and Microsoft, AI in drug discovery specialist Exscientia, genomics ...

Feel like there are already a lot of store closing announcements in 2025? Here's a list of retailers closing stores in and ...

Former DeepMind scientist Simon Kohl has raised $50 million for Latent Labs, a London-based AI startup aiming to transform ...

Backed by influencial names in the life sciences industry, Latent Labs offers an AI platform to accelerate and improve drug ...

The company is developing generative AI methods to design proteins from scratch, with applications in drug discovery and ...

Former DeepMind employees raise $40 million to launch London-based startup 'laser-focused' on AI protein design.

Latent Labs hopes to take computational biology one step further. The company is developing foundation AI models that don’t ...

Isomorphic Labs, a spin-off from DeepMind, is applying AI-first principles to drug discovery rather than just protein ...

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life ...